Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain

Transfusion

Volumn 50, Issue 1, 2010, Pages 221-230

  González, Rocio ^a,b,c,d,e,f   Torres, Pilar ^a,b,c,d,e,f   Castro, Emma ^a,b,c,d,e,f   Barbolla, Luz ^a,b,c,d,e,f   Candotti, Daniel ^a,b,c,d,e,f   Koppelman, Marco ^a,b,c,d,e,f   Zaaijer, Hans L ^a,b,c,d,e,f   Lelie, Nico ^a,b,c,d,e,f   Allain, Jean Pierre ^a,b,c,d,e,f   Echevarría, Jose Manuel ^a,b,c,d,e,f  

^a Transfusion Center of the Community of Madrid ^*  (Spain)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c SANQUIN RESEARCH   (Netherlands)

^d Chiron   (France)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AGED; AMINO ACID SUBSTITUTION; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD BANK; BLOOD DONOR; CONVALESCENCE; DNA SCREENING; GENE FREQUENCY; GENOMIC FRAGMENT; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; SPAIN;

ACUTE DISEASE; ADULT; BLOOD BANKS; BLOOD TRANSFUSION; DNA, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MASS SCREENING; SPAIN; TRANSAMINASES;

EID: 73649124240     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02343.x     Document Type: Article

References (38)

1. Álvarez M, Oyonarte S, Rodríguez PM, Hernandez JM. Estimated risk of transfusion-transmitted viral infections in Spain. Transfusion 2002 42 : 994 8.
2. Álvarez M, González R, Hernández JM. Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing. Eurosurveillance 2005 10 : 20 2.
3. González R, Echevarría JM, Avellón A, Barea L, Castro E. Acute hepatitis B window-period blood donations detected by individual-donation nucleic acid testing: a report of the first two cases found and interdicted in Spain. Transfusion 2006 46 : 1138 42.
4. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007 46 : 160 70.
5. Yoshikawa A, Gotanda Y, Mineshigi K, Aira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Misoguchi H. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007 47 : 1162 70.
6. Manzini P, Abate ML, Valpreda C, Milanesi P, Curti F, Rizzetto M, Smedile A. Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor. Transfusion 2009 49 : 757 64.
7. Tabor E, Hoofnagle JH, Smallwood LA, Drucker JA, Pineda-Tamondong GC, Ni LY, Greenwalt TJ, Barker LF, Gerety RJ. Studies of donors who transmit post transfusion hepatitis. Transfusion 1979 19 : 725 31.
8. García-Montalvo BM, Farfán JA, Acosta KY, Puerto FI. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatán, México. Transfus Med 2005 15 : 371 8.
9. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology 2006 44 : 1666 74.
10. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007 47 : 1197 205.
11. Chevrier MC, ST-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007 47 : 1794 802.
12. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica 2007 92 : 1664 70.
13. Zahn A, Li C, Danso K, Candotti D, Owusu-Ofori S, Temple J, Allain JP. Molecular characterization of occult hepatitis B virus in genotype E-infected patients. J Gen Virol 2008 89 : 409 18.
14. Zaaijer HL, Torres P, Ontañón A, Ponte LG, Koppelman MH, Lelie PN, Hemert FJ, Boot HJ. Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infections. J Med Virol 2008 80 : 1344 9.
15. Candotti D, Grabarczyk P, Ghiazza P, Roig R, Casamitjana N, Iudicone P, Schmidt M, Bird A, Crookes R, Brojer E, Miceli M, Amiri A, Li C, Allain JP. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 2008 49 : 537 47.
16. Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion 2008 48 : 2205 13.
17. Saldanha J, Lelie N, Heath A. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study Group. Vox Sang 1999 76 : 149 58.
18. Koppelman MH, Zaaijer HL. Diversity and origin of hepatitis B virus in Dutch blood donors. J Med Virol 2004 73 : 29 32.
19. Echevarría JM, Avellón A. Hepatitis B virus genetic diversity. J Med Virol 2006 78 : S36 S42.
20. Bremer CM, Saniewski M, Wend U, Torres P, Lelie N, Gerlich WH, Glebe D. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 2009 49 in press.
21. Norder H, Couroucé AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes and HBsAg subtypes. Intervirology 2004 47 : 289 309.
22. Levicnik-Stezinar S. Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay. Clin Lab 2004 50 : 49 51.
23. Coste J, Reesink HW, Engelfriet CP, Laperche S, Brown S, Busch MP, Cuijpers HT, Elgin R, Ekermo B, Epstein JS, Flesland O, Heier HE, Henn G, Hernandez JM, Hewlett IK, Hyland C, Keller AJ, Krusius T, Levicnik-Stezina S, Levy G, Lin CK, Margaritis AR, Muylle L, Niederhauser C, Pastila S, Pillonel J, Pineau J, van der Poel CL, Politis C, Roth WK, Sauleda S, Seed CR, Sondag-Thull D, Stramer SL, Strong M, Vamvakas EC, Velati C, Vesga MA, Zanetti A. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang 2005 88 : 289 303.
24. Koppelman M, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT. Multi-center performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA and hepatitis B virus DNA in blood donations. Transfusion 2005 45 : 1258 66. (Pubitemid 41647788)
25. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, David B, De Micco P. Comparison of the analytical and operational performance of two nucleic acid test blood screening systems: Procleix Tigris and Cobas s 201. Transfusion 2009 49 : 289 300.
26. Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, LaPerche S. Sensitivity of hepatitis B virus transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations. Transfusion 2006 46 : 2047 52.
27. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS Ampliscreen HBV test. Transfusion 2005 45 : 1247 57.
28. Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Lin Tsai SJ. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 2008 48 : 1198 206.
29. Lubel JS, Testro AG, Angus PW. Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management. Intern Med J 2007 37 : 705 12.
30. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008 48 : 1022 5.
31. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R. Impact of individual donation (ID) nucleic acid testing (NAT) on risk of HIV, HBV and HCV transmission by blood transfusion in South Africa. Transfusion 2009 49 : 1115 25.
32. Echevarría JM, Avellón A, Magnius LO. Molecular epidemiology of hepatitis B virus in Spain: identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol 2005 76 : 176 84.
33. Avellón A, Echevarría JM. Frequency of hepatitis B virus "a" determinant variants in unselected Spanish carriers. J Med Virol 2006 78 : 24 36.
34. Mühlbacher A, Weber B, Burgisser P, Eiras A, Cabrera J, Louisirirotchanakul S, Tiller FW, Kim HS, v Helden J, Bossi V, Echevarria JM. Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants. Med Microbiol Immunol 2008 197 : 55 64.
35. Echevarría JM, Avellón A. Improved detection of natural hepatitis B virus surface antigen (HBsAg) variants by a new version of the VITROS® HBsAg assay. J Med Virol 2008 80 : 598 602.
36. Michalak TI. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model. Immunol Rev 2000 174 : 98 111.
37. Gerlich WH, Wagner FF, Chudy M, Harritshoj LH, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schuttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E. HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2007 79 : S32 S36.
38. Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, Barbosa LH, Nemo GJ. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995 35 : 5 12.